e.g. Tata motors, Reliance MF, 500570

Aarti Drugs Ltd. - Research Center

524348 AARTIDRUGS Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 26 Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22
Income
Operating income 2,260.39 2,173.65 2,266.91 2,497.97 2,251.17
Expenses
Material consumed 1,469.12 1,431.96 1,564.06 1,775.86 1,529.31
Manufacturing expenses 354.14 318.99 292.00 286.45 258.43
Personnel expenses 96.27 85.25 80.98 74.99 69.32
Selling expenses 1.18 0.69 1.08 0.35 0.35
Adminstrative expenses 78.94 74.12 62.65 77.91 75.58
Expenses capitalised - - - - -
Cost of sales 1,999.66 1,911.00 2,000.78 2,215.57 1,932.99
Operating profit 260.73 262.65 266.13 282.40 318.18
Other recurring income 2.59 13.57 4.18 2.23 4.77
Adjusted PBDIT 263.32 276.22 270.31 284.64 322.96
Financial expenses 26.38 29.68 30.16 32.53 20.07
Depreciation 55.64 47.79 47.67 47.29 47.39
Other write offs - - - - -
Adjusted PBT 181.31 198.75 192.48 204.81 255.50
Tax charges 12.08 41.44 50.60 52.00 60.50
Adjusted PAT 169.22 157.31 141.88 152.81 195.00
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 169.22 157.31 141.88 152.81 195.00
Earnigs before appropriation 1,295.70 1,209.63 1,089.02 971.67 899.26
Equity dividend 18.25 9.13 9.19 9.26 9.26
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 1,277.45 1,200.50 1,079.82 962.41 890.00
Close
Add Aarti Drugs Ltd. to your Portfolio
 
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aarti Drugs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback